You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging II1 Apr 2016MP78-19 DO RENIN-ANGIONTENSIN BLOCKERS AFFECT RENAL FUNCTION AND ADVERSE OUTCOMES IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY? Yaw A. Nyame, Helen Liang, Hans Arora, Bradley Gill, Peter Caputo, Daniel Ramirez, Khaled Fareed, Robert Stein, Georges-Pascal Haber, Andrew J. Stephenson, Amr Fergany, and Jihad Kaouk Yaw A. NyameYaw A. Nyame More articles by this author , Helen LiangHelen Liang More articles by this author , Hans AroraHans Arora More articles by this author , Bradley GillBradley Gill More articles by this author , Peter CaputoPeter Caputo More articles by this author , Daniel RamirezDaniel Ramirez More articles by this author , Khaled FareedKhaled Fareed More articles by this author , Robert SteinRobert Stein More articles by this author , Georges-Pascal HaberGeorges-Pascal Haber More articles by this author , Andrew J. StephensonAndrew J. Stephenson More articles by this author , Amr FerganyAmr Fergany More articles by this author , and Jihad KaoukJihad Kaouk More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1975AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The cardiothoracic literature recently suggested that cessation of renin-angiotensin system (RAS) blockers may increase the risk of adverse perioperative outcomes. Some surgeons hold RAS blockers and other medications affecting renal function in the immediate post-operative period following renal surgery. This study assessed the effects of RAS blocker resumption on renal function and adverse outcomes after robotic-assisted laparoscopic partial nephrectomy (RALPN). METHODS A retrospective analysis of patients who underwent RALPN at a large academic medical center from 2006- 2014 was performed. Relevant covariates perioperative glomerular filtration rate (GFR) and postoperative adverse events were collected via review of the electronic medical record. Patients were classified as having either immediate (postoperative day 1) or delayed (at or after discharge) resumption of RAS blockade. Patients with prior renal surgery, planned staged renal surgeries, or a history of solitary kidney were excluded. Comparative statistics were performed with Wilcoxon rank-sum and ?2 tests. Data are presented as median (interquartile range). RESULTS A cohort of 901 patients with median follow-up of 10.4(1.4-30.8) months was identified. Median age of patients on RAS blockers was 63.0 (56.0-70.0) compared to 57.0 (49.0-66.0) years in those without (p < 0.001), and 40.7% of patients were women. In total, 338 patients were on RAS blockade at the time of surgery with 219/338 (64.8 %) on angiotensin converting enzyme inhibitors and 119/338 (35.2%) on angiotensin receptor blockers. Of these patients, 137 (41.9 %) resumed RAS blockade immediately. Among patients on RAS blockade, immediate resumption did not significantly impact postoperative day 3 GFR [70.1(54.4-87.4) vs 69.9 (56.1-84.0) p = 0.81]. Similarly immediate versus delayed RAS blockade resumption did not significantly change stage 4-5 CKD rates (GFR < 30 ml/min) at last recorded follow-up (3.3% vs. 4.3%, p = 0.45). There was no significant difference in postoperative cardiovascular events (arrhythmia or infarction), with or without immediate RAS blocker resumption (6.6% vs. 4.7%, p = 0.47). However, with malignancy on final pathology, immediate RAS blockade resumption was associated with significantly decreased mortality (0.10%; p = 0.02). CONCLUSIONS RAS blockers appear safe to continue immediately postoperatively in patients undergoing RALPN. Despite increased age, immediate resumption of RAS blockers was associated with improved survival in patients with cancer on final pathology. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e1033-e1034 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Yaw A. Nyame More articles by this author Helen Liang More articles by this author Hans Arora More articles by this author Bradley Gill More articles by this author Peter Caputo More articles by this author Daniel Ramirez More articles by this author Khaled Fareed More articles by this author Robert Stein More articles by this author Georges-Pascal Haber More articles by this author Andrew J. Stephenson More articles by this author Amr Fergany More articles by this author Jihad Kaouk More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract